Skip to content

Investigation of the effect of electrical stimulation on patients undergoing lower limb revascularization surgery

Effectiveness of Neuromuscular Electrical Stimulation in Patients undergoing Lower Extremity Revascularization Surgery. - Effectiveness of Neuromuscular Electrical Stimulation in Patients undergoing Lower Extremity Revascularization Surgery.

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
JPRN
Registry ID
JPRN-UMIN000056700
Enrollment
20
Registered
2025-01-14
Start date
2025-01-14
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Peripheral Arterial Disease

Interventions

The neuromuscular electrical stimulation group will receive neuromuscular electrical stimulation of the bilateral triceps muscles in addition to a program compliant with the usual rehabilitation progr

Sponsors

Nihon Fukushi University
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: Patients who required inpatient care for lower limb revascularization surgery and had a prescription for physical therapy.

Exclusion criteria

Exclusion criteria: Patients who could not be assessed for activities of daily living or physical function, who are not ambulatory independently, or who had to undergo reoperation due to postoperative events. In addition, the following are contraindications or prohibitions for POSTIM, a neuromuscular electrical stimulation device. Patients with certain implantable electronic devices such as pacemakers, hematochezia, areas of moderate or greater edema, areas of sensory disturbance, patients with acute (painful) disease of unknown cause, patients with heart problems, patients with a high predisposition to bleeding, patients with malignant tumors, pregnant women, injured or inflamed skin areas, febrile disease patients with contagious diseases, patients with skin surface with venous irritation (veins protruding), patients with metal or plastic implants (artificial heads, implanted nails, etc.) in the body, patients who are at risk of thrombosis, venous thrombosis, varicose veins or other vascular disorders, patients on carotid sinus, and other patients deemed inappropriate by the physician.

Design outcomes

Primary

MeasureTime frame
The test is the prolongation of walking distance in the 6-minute walk test after 3 months of treatment, and evaluates whether the neuromuscular electrical stimulation group is superior to the control group.

Secondary

MeasureTime frame
Physical activity at 3 and 12 months post-treatment will be evaluated to determine if improvement in physical activity was associated with prevention of restenosis.

Countries

Japan

Contacts

Public ContactMasahiro Yamamoto

Aichi Medical University Hospital Department of Rehabilitation

yamamoto.masahiro.223@mail.aichi-med-u.ac.jp0561-62-3311

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026